| 2026-06-11 16:44 |
8-K |
["1.01", "1.02"] |
merger agreement |
1.00
|
Definitive merger agreement with Chiesi Farmaceutici; tender offer completed at $27/share; merger consummated June 11, 2026. |
SEC · detail |
| 2026-06-11 09:03 |
SC TO-T |
|
tender offer |
1.00
|
Completed tender offer: Chiesi acquired KalVista at $27/share; 77.8% tendered, merger effective June 11, 2026. |
SEC · detail |
| 2026-06-11 08:57 |
SC 14D9 |
|
tender offer |
1.00
|
Completed tender offer and merger: Chiesi acquired KalVista at $27/share; 77.8% tendered; merger effective June 11, 2026. |
SEC · detail |
| 2026-06-01 09:05 |
SC TO-T |
|
tender offer |
0.98
|
Chiesi Farmaceutici's tender offer for KalVista at $27/share; Amendment 1 confirms HSR clearance and regulatory approvals. |
SEC · detail |
| 2026-06-01 09:05 |
SC 14D9 |
|
tender offer |
0.98
|
SC 14D-9/A amendment for active tender offer by Chiesi Farmaceutici at $27.00/share cash. |
SEC · detail |
| 2026-05-13 16:45 |
SC 14D9 |
|
tender offer |
0.98
|
SC 14D-9 filed by KalVista in response to definitive tender offer by Chiesi Farmaceutici at $27/share with merger agreement dated April 29, 2026. |
SEC · detail |
| 2026-05-13 07:22 |
SC TO-T |
|
tender offer |
0.98
|
SC TO-T filing: Chiesi Farmaceutici via Skyline Merger Sub conducting third-party tender offer for KalVista at $27.00/share. |
SEC · detail |
| 2026-04-29 08:30 |
8-K |
["1.01"] |
merger agreement |
0.98
|
KalVista entered into merger agreement with Chiesi Farmaceutici; tender offer for $27/share commencing within 10 business days. |
SEC · detail |